4/10
08:05 am
cara
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Medium
Report
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
4/10
06:33 am
cara
Rating for CARA
Low
Report
Rating for CARA
4/10
06:33 am
cara
Rating for CARA
Low
Report
Rating for CARA
3/28
08:07 am
cara
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Low
Report
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
3/28
05:38 am
cara
Rating for CARA
Low
Report
Rating for CARA
3/28
05:38 am
cara
Rating for CARA
Low
Report
Rating for CARA
3/6
06:57 am
cara
Rating for CARA
High
Report
Rating for CARA
3/5
08:15 am
cara
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Medium
Report
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
3/5
06:29 am
cara
Rating for CARA
Low
Report
Rating for CARA
3/5
06:29 am
cara
Rating for CARA
Low
Report
Rating for CARA
1/22
05:06 pm
cara
Rating for CARA
Report
Rating for CARA
1/22
05:06 pm
cara
Rating for CARA
Report
Rating for CARA